Bullish option flow detected in Bristol Myers Squibb with 13,467 calls trading, 1.7x expected, and implied vol increasing over 3 points to 25.80%. 3/28 weekly 53 calls and Oct-24 55 calls are the most active options, with total volume in those strikes near 8,300 contracts. The Put/Call Ratio is 0.34. Earnings are expected on April 25th.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers’ Abecma approved in the EU for multiple myeloma
- Bristol Myers says Phase 3 CheckMate -9DW trial met primary endpoint
- Bristol Myers announces the Phase 3 CheckMate -9DW trial
- This radiopharma name seen as ‘poised for takeout’ following Fusion deal
- Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim